O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+7.9%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$3.98B
AUM Growth
+$3.98B
(-4.5%)
Cap. Flow
-$356M
Cap. Flow
% of AUM
-8.96%
Top 10 Holdings %
Top 10 Hldgs %
49.18%
Holding
122
New
13
Increased
19
Reduced
24
Closed
22
Top Buys
| 1 |
CAI
Caris Life Sciences, Inc. Common Stock
CAI
|
$81.1M |
| 2 |
UnitedHealth
UNH
|
$42.1M |
| 3 |
Roivant Sciences
ROIV
|
$31.3M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$22.4M |
| 5 |
CytomX Therapeutics
CTMX
|
$19.2M |
Top Sells
| 1 |
Pfizer
PFE
|
$97.6M |
| 2 |
Ionis Pharmaceuticals
IONS
|
$76.6M |
| 3 |
Neurocrine Biosciences
NBIX
|
$62.4M |
| 4 |
SWTX
SpringWorks Therapeutics
SWTX
|
$41.9M |
| 5 |
Xtant Medical Holdings
XTNT
|
$34.4M |
Sector Composition
| 1 | Healthcare | 99.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMA
76
ImageneBio, Inc. Common Stock
IMA
$153M
| $4.74M | 0.12% |
3,539,358
| – | – |
|
77
Repare Therapeutics
RPTX
$73.9M
| $4.62M | 0.12% |
3,322,488
| – | – |
|
78
Immatics
IMTX
$662M
| $3.87M | 0.1% |
719,901
-2,367,561
| -77% | -$12.7M |
|
|
BIOA
79
BioAge Labs, Inc. Common Stock
BIOA
$170M
| $3.81M | 0.1% |
921,959
| – | – |
|
80
Q32 Bio
QTTB
$20.9M
| $3.36M | 0.08% |
2,252,987
| – | – |
|
81
enGene Holdings
ENGN
$249M
| $2.47M | 0.06% |
677,977
-213,639
| -24% | -$778K |
|
82
Passage Bio
PASG
$22.7M
| $2.42M | 0.06% |
6,055,300
-979,326
| -14% | -$392K |
|
83
Amylyx Pharmaceuticals
AMLX
$877M
| $2.01M | 0.05% |
313,200
-34,800
| -10% | -$223K |
|
84
Mural Oncology
MURA
$35.9M
| $1.45M | 0.04% |
+588,800
| New | +$1.45M |
|
85
Insmed
INSM
$30.3B
| $1.35M | 0.03% |
13,459
-15,200
| -53% | -$1.53M |
|
86
Krystal Biotech
KRYS
$4.35B
| $1.26M | 0.03% |
9,200
-14,300
| -61% | -$1.97M |
|
|
TSBX
87
DELISTED
Turnstone Biologics
TSBX
| $1.11M | 0.03% |
3,099,265
| – | – |
|
|
CMMB
88
Chemomab Therapeutics
CMMB
$15.7M
| $1.09M | 0.03% |
940,990
-800,283
| -46% | -$928K |
|
89
Traws Pharma
TRAW
$11.4M
| $896K | 0.02% |
605,531
| – | – |
|
90
Kezar Life Sciences
KZR
$28.5M
| $883K | 0.02% |
192,700
| – | – |
|
91
Alto Neuroscience
ANRO
$97.7M
| $550K | 0.01% |
250,000
| – | – |
|
92
DIH Holdings US
DHAI
$12.2M
| $469K | 0.01% |
1,915,000
| – | – |
|
93
Lyell Immunopharma
LYEL
$220M
| $457K | 0.01% |
+51,727
| New | +$457K |
|
94
Korro Bio
KRRO
$245M
| $405K | 0.01% |
32,400
| – | – |
|
95
Xeris Biopharma Holdings
XERS
$1.27B
| $376K | 0.01% |
80,420
| – | – |
|
|
LSB
96
LakeShore Biopharma
LSB
$34.9M
| $55.9K | ﹤0.01% |
54,799
-85,629
| -61% | -$87.3K |
|
|
KMTS
97
Kestra Medical Technologies, Ltd. Common Stock
KMTS
$871M
| – | – |
-250,000
| Closed | -$6.23M |
|
|
CBLL
98
CeriBell, Inc. Common Stock
CBLL
$426M
| – | – |
-112,500
| Closed | -$2.16M |
|
|
BCAX
99
Bicara Therapeutics Inc. Common Stock
BCAX
$655M
| – | – |
-298,301
| Closed | -$3.89M |
|
|
100
Xtant Medical Holdings
XTNT
$82.4M
| – | – |
-73,114,592
| Closed | -$34.4M |
|